Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Richard W. Barker"'
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background One of the functions of the reformed Cancer Drugs Fund in England is as a managed access fund, providing conditional funding for cancer drugs where there is uncertainty in the economic case, and where that uncertainty can be addre
Externí odkaz:
https://doaj.org/article/c3b330e10bbf444dbdf25aba3ba7d2f3
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-1 (2019)
Externí odkaz:
https://doaj.org/article/c8af85639a5d4f24a15a39059a629ed2
Publikováno v:
Pharmacoeconomics
Background Decisions on funding new healthcare technologies assume that all health improvements are valued equally. However, public reaction to health technology assessment (HTA) decisions suggests there are health attributes that matter deeply to th
Autor:
Benjamin M Davies, Sarah Rikabi, Anna French, Rafael Pinedo-Villanueva, Mark E Morrey, Karolina Wartolowska, Andrew Judge, Robert E MacLaren, Anthony Mathur, David J Williams, Ivan Wall, Martin Birchall, Brock Reeve, Anthony Atala, Richard W Barker, Zhanfeng Cui, Dominic Furniss, Kim Bure, Evan Y Snyder, Jeffrey M Karp, Andrew Price, Andrew Carr, David A Brindley
Publikováno v:
Journal of Tissue Engineering, Vol 5 (2014)
There has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this magnitude of activity. We hyp
Externí odkaz:
https://doaj.org/article/16702e59821c4beaa187e0c04cb06840
Autor:
Richard W. Barker
Publikováno v:
Personalized Medicine. 14:459-461
Autor:
Richard W Barker, Sarah Garner
Publikováno v:
Reviews on Recent Clinical Trials. 10:19-24
The recent launch of a pilot scheme for 'adaptive licensing' by the European Medicines Agency could spell a new era in drug development. Rather than focusing on the purely regulatory aspect of the system, the proposals challenge several aspects of ex
Autor:
Jack W. Scannell, Richard W. Barker
Publikováno v:
Therapeutic Innovation & Regulatory Science. 49:415-424
In recent years, concern has been growing that traditional research and development models in the life sciences are unsustainable. Productivity, especially in pharmaceuticals, has plummeted, and too many of the products emerging from increasingly len
Autor:
Amit Chandra, Mahendra S. Rao, Hae-Won Kim, Doug Sipp, Glyn Stacey, Guillermo García-Cardeña, Joseph C. Wu, Alexander Meissner, Jonathan C. Knowles, Natalie Artzi, Joseph D. Gold, Andrew Carr, David Brindley, Ivan B. Wall, Christopher A. Bravery, David J. Williams, Peter R.T. Archibald, Richard W. Barker, James R. Smith, Kim Bure, Anna French, Jeanne F. Loring, Brock Reeve, Evan Y. Snyder, Jeffrey M. Karp, Steve Oh
Publikováno v:
Stem Cells Translational Medicine. 4:217-223
Summary There is a need for physical standards (reference materials) to ensure both reproducibility and consistency in the production of somatic cell types from human pluripotent stem cell (hPSC) sources. We have outlined the need for reference mater
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-1 (2019)
BMC Health Services Research
BMC Health Services Research
One of the functions of the reformed Cancer Drugs Fund in England is as a managed access fund, providing conditional funding for cancer drugs where there is uncertainty in the economic case, and where that uncertainty can be addressed by data collect
Autor:
M May, I Bingham, Christopher A. Bravery, M S Rattley, Amit Chandra, Andrew Judge, Andrew Carr, Ivan B. Wall, Gilles Lemaitre, E Titus, B Siegel, Benjamin Davies, K Rooke, Y. Laabi, Richard W. Barker, A Kramm, Anna French, M Morys, Rafael Pinedo-Villanueva, R L Buckler, David J. Williams, Liam M. Grover, Rob Horne, Douglas Sipp, Mark E. Morrey, David Brindley, Brock Reeve, Afsie Sabokbar, Mackenna Roberts, R Zahkia, Evan Y. Snyder, Jeffrey M. Karp, J Suh, K Krumholz, Hannah Hurley, Sarah Rikabi, D McKeon, Karolina Wartolowska, R Pigott, L Hook, Kim Bure
Publikováno v:
Stem Cells and Development. 22:63-72
Increased global connectivity has catalyzed technological development in almost all industries, in part through the facilitation of novel collaborative structures. Notably, open innovation and crowd-sourcing-of expertise and/or funding-has tremendous